Aveanna Healthcare is a diversified home care platform focused on treating medically complex, high-cost patient populations in their preferred home setting.
Aveanna achieved substantial growth in fiscal year 2025, generating a total revenue of $2,433.2 million. Furthermore, the company reported a full-year net income per diluted share (EPS) of $1.05. Fourth-quarter revenue alone reached $662.5 million.
The company’s full-year Adjusted EBITDA rose to $320.9 million. Aveanna also generated $131.0 million in free cash flow during 2025. Additionally, they announced a definitive agreement to acquire Family First Homecare for $175.5 million
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.
The post Aveanna Healthcare Reports Strong 2025 Financial Results first appeared on Alphastreet.
